Skip to main content
Equibles

Tower Research Capital LLC (TRC)

Position in APUS — Apimeds Pharmaceuticals US, Inc.

CIK 1533421 NEW YORK, NY
Back to APUS Full portfolio

Position in APUS

as of Jun 30, 2026 · filed Aug 11, 2026
Position Value
$1,497
+$1,497 QoQ
Shares Held
166
+16500.0% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#7
of 7 holders
Holding Since
Jun 2025
3 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in APUS Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Tower Research Capital LLC (TRC) holds $14,082,412 across 58 Drug Manufacturers - Specialty & Generic names. APUS ranks #53 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 HIMS
Hims & Hers Health, Inc.
 111,351 $3,860,538
2 UTHR
UNITED THERAPEUTICS Corp
 3,880 $2,102,300
3 ZTS
Zoetis Inc.
 24,069 $1,729,598
4 NBIX
Neurocrine Biosciences Inc
 7,270 $1,225,285
5 ELAN
Elanco Animal Health Inc
 38,301 $942,587
6 LNTH
Lantheus Holdings, Inc.
 6,773 $751,395
7 ALKS
Alkermes plc.
 6,157 $322,626
8 INDV
Indivior Pharmaceuticals, Inc.
 7,032 $288,522

All Filings in APUS

Export CSV
3 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,497 1,664
2025-12-31 — 10
2025-06-30 — 3,151